7th Edition of Neurology World Conference 2027

Parkinson's disease is one of the fastest-growing neurological disorders in the world. Globally, around 11 million patients are suffering from Parkinson’s disease. In the USA, every year 90,000 people are newly diagnosed with PD. For patients, it can mean a tremor that makes it hard to hold a cup, stiffness that slows every step, and symptoms that reach well beyond movement, from sleep problems to changes in mood and memory.

This track covers PD, essential tremors, dystonia, Huntington's disease, and atypical parkinsonian syndromes. The sessions will cover earlier diagnosis using skin and spinal fluid tests for alpha-synuclein, the role of genetic subtypes such as GBA and LRRK2, and the growing range of treatments, from new drug delivery options to deep brain stimulation and focused ultrasound. The session also covers the current treatment options in clinical trials and their various phases of development.

Movement disorder specialists, neurologists, neurosurgeons, physical therapists, nurses, and researchers are invited to share work that helps people stay active and independent for longer

Topics include:

• Early diagnosis and alpha-synuclein biomarkers
• Genetics of Parkinson's disease
• Essential tremors and dystonia
• Huntington's disease and atypical parkinsonism
• Advanced therapies: DBS, focused ultrasound, and infusion treatments
• Disease-modifying therapies in development
• Non-motor symptoms: sleep, mood, and cognition
• Exercise and rehabilitation in movement disorders

Come and share the progress that is helping people with movement disorders keep moving.